ALLMedicine™ Von Willebrand Disease Center
Research & Reviews 804 results
https://doi.org/10.1016/j.jogc.2022.03.017
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Kazi S, Arusi I et. al.
May 16th, 2022 - Higher rates of postpartum hemorrhage (PPH) have been reported for women with von Willebrand disease (VWD). Comprehensive multidisciplinary care reduces these rates; thus PPH may not be secondary to VWD. We conducted a retrospective review for the...
https://doi.org/10.2450/2022.0329-21
Blood Transfusion = Trasfusione Del Sangue; Gouider E, Klukowska A et. al.
May 12th, 2022 - Plasma-derived von Willebrand factor (VWF) (Wilfactin®, LFB, France) was developed for prophylaxis and treatment of haemorrhages in both adults and adolescents with von Willebrand disease (VWD). Replacement therapy in paediatric patients is a key ...
https://doi.org/10.1111/ejh.13785
European Journal of Haematology; Castaman G, Borchiellini A et. al.
May 10th, 2022 - The present review aims to summarize the state-of-the-art VWD treatment focusing on specific clinical settings (obstetrics, surgery, long-term prophylaxis and comorbidities) as well as on the use of a VWF concentrate with low FVIII content. Litera...
https://doi.org/10.1007/s12185-022-03372-2 10.1182/blood-2012-10-462085 10.1111/j.1365-2516.2008.01679.x 10.1007/978-1-4613-0331-2_7 10.1055/s-0037-1607440 10.1111/bjh.13064 10.1046/j.1538-7836.2003.00009.x 10.1160/TH12-03-0136 10.1111/bjh.14805 10.1160/TH12-02-0089 10.1111/hae.13075 10.1002/ajh.24777 10.1177/1076029607310920 10.1097/MBC.0000000000000865 10.1111/j.1600-0609.1987.tb01458.x 10.1055/s-0037-1613799 10.1111/j.1365-2516.2012.02799.x 10.1160/TH15-10-0780 10.1007/s002770050323
International Journal of Hematology; Chikasawa Y, Hagiwara T et. al.
May 10th, 2022 - Type 3 von Willebrand disease (VWD), a rare and severe subtype, can produce inhibitors in roughly 5% to 10% of cases. We present a case of type 3 VWD with inhibitors in late pregnancy, which was successfully managed with a combination of neutraliz...
https://clinicaltrials.gov/ct2/show/NCT04398628
May 10th, 2022 - This is a longitudinal, natural history observational cohort study being conducted at approximately 150 ATHN-affiliated sites. Participants will be followed for a minimum of 15 years. Harmonized data elements will be collected at time of enrollmen...
Guidelines 4 results
https://doi.org/10.1016/j.jogc.2017.11.036
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Demers C, Derzko C et. al.
Feb 16th, 2018 - The prevalence of bleeding disorders, notably von Willebrand disease (vWD), among adult women with objectively documented menorrhagia is consistently reported to be 10% to 20% and is even higher in adolescents presenting with menorrhagia. Diagnost...
https://doi.org/10.2450/2008.0052-08
Blood Transfusion = Trasfusione Del Sangue; Mannucci PM, Franchini M et. al.
Jun 9th, 2009 - von Willebrand disease (VWD) is the most common hereditary bleeding disorder affecting both males and females. It arises from quantitative or qualitative defects of von Willebrand factor (VWF) and causes bleeding of mucous membranes and soft tissu...
https://doi.org/10.1002/ajh.21405
American Journal of Hematology; Nichols WL, Rick ME et. al.
May 6th, 2009 - Von Willebrand factor (VWF) mediates blood platelet adhesion and accumulation at sites of blood vessel injury, and also carries coagulation factor VIII (FVIII) that is important for generating procoagulant activity. Von Willebrand disease (VWD), t...
https://doi.org/10.1111/j.1365-2516.2007.01643.x
Haemophilia : the Official Journal of the World Federatio... Nichols WL, Hultin MB et. al.
Mar 5th, 2008 - von Willebrand disease (VWD) is a commonly encountered inherited bleeding disorder affecting both males and females, causing mucous membrane and skin bleeding symptoms, and bleeding with surgical or other haemostatic challenges. VWD may be disprop...
Drugs 19 results see all →
Clinicaltrials.gov 29 results
https://clinicaltrials.gov/ct2/show/NCT04398628
May 10th, 2022 - This is a longitudinal, natural history observational cohort study being conducted at approximately 150 ATHN-affiliated sites. Participants will be followed for a minimum of 15 years. Harmonized data elements will be collected at time of enrollmen...
https://clinicaltrials.gov/ct2/show/NCT02606045
Mar 2nd, 2022 - In this study, women age 13-45 years with mild to moderate VWD and menorrhagia will be enrolled at their hemophilia treatment centers (HTCs) and provide information on menstrual bleeding from their two past monthly cycles to establish baseline ble...
https://clinicaltrials.gov/ct2/show/NCT04953884
Feb 21st, 2022 - The WIL-33 study aims to determine the efficacy, pharmacokinetics, immunogenicity and safety of wilate as routine prophylaxis in up to 12 paediatric patients (eight evaluable) with severe von Willebrand Disease VWD (defined as screening von Willeb...
https://clinicaltrials.gov/ct2/show/NCT02973087
Aug 6th, 2021 - The purpose of this phase 3 study is to investigate the efficacy and safety, including immunogenicity, thrombogenicity and hypersensitivity reactions, as well as pharmacokinetics (PK), health related quality of life (HRQoL) and pharmacoeconomics o...
https://clinicaltrials.gov/ct2/show/NCT02283268
May 19th, 2021 - The purpose of the study is to assess the efficacy and safety of recombinant von Willebrand factor (rVWF) with or without ADVATE in major and minor elective surgical procedures in adult patients with hereditary severe von Willebrand disease (VWD).
News 35 results
https://www.mdedge.com/hematology-oncology/article/236987/bleeding-disorders/type-3-von-willebrand-rare-serious-bleeding
Neil Osterweil
Mar 10th, 2021 - Type 3 von Willebrand disease (VWD) is rare, but this form of the disease is associated with severe bleeding, particularly in muscles and joints, a bleeding disorders expert said. “There’s a virtually complete deficiency in von Willebrand factor [.
https://www.mdedge.com/hematology-oncology/article/234756/bleeding-disorders/von-willebrand-disease-guidelines-address
Neil Osterweil
Jan 19th, 2021 - New guidelines issued jointly by four major international hematology groups focus on the management of patients with von Willebrand disease (VWD), the most common bleeding disorder in the world. The evidence-based guidelines, published in Blood Ad.
https://www.mdedge.com/obgyn/article/204480/bleeding-disorders/labor-outcomes-unchanged-alternate-anesthesia-bleeding?channel=27970
Caleb Rans
Jul 11th, 2019 - Among pregnant women with inherited bleeding disorders, having a contraindication to regional anesthesia appears not to impact labor outcomes, according to a retrospective analysis. oceandigital/Thinkstock “The purpose of this study was to determi.
https://reference.medscape.com/viewarticle/915458
Jul 11th, 2019 - Bleeding disorders are conditions in which an individual's blood does not properly clot. Although hemophilia is perhaps the most well-known bleeding disorder, it is somewhat rare. Although it is typically less severe than other similar conditions,...
https://reference.medscape.com/viewarticle/915458_1
Jul 11th, 2019 - Bleeding disorders are conditions in which an individual's blood does not properly clot. Although hemophilia is perhaps the most well-known bleeding disorder, it is somewhat rare. Although it is typically less severe than other similar conditions,...